Aveanna Healthcare Holdings Research and Development Expenses 2020-2024 | AVAH
Aveanna Healthcare Holdings research and development expenses from 2020 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
| Aveanna Healthcare Holdings Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $ |
| 2022 | $ |
| 2021 | $ |
| 2020 | $ |
| 2019 | $ |
| Aveanna Healthcare Holdings Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | $0 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.149B | $1.895B |
| Aveanna Healthcare Holdings Inc. is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna Healthcare Holdings Inc. is based in Atlanta, Georgia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $20.039B | 12.12 |
| Quest Diagnostics (DGX) | United States | $17.877B | 18.12 |
| DaVita (DVA) | United States | $12.667B | 16.38 |
| Encompass Health (EHC) | United States | $10.405B | 24.53 |
| Chemed (CHE) | United States | $8.459B | 26.00 |
| Elanco Animal Health (ELAN) | United States | $7.054B | 16.79 |
| RadNet (RDNT) | United States | $6.388B | 141.61 |
| Option Care Health (OPCH) | United States | $3.890B | 18.43 |
| Amedisys (AMED) | United States | $3.035B | 21.60 |
| LifeStance Health (LFST) | United States | $2.828B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.320B | 27.22 |
| Astrana Health (ASTH) | United States | $2.297B | 36.01 |
| U.S Physical Therapy (USPH) | United States | $1.428B | 37.54 |
| Pennant (PNTG) | United States | $1.162B | 46.99 |
| Atai Life Sciences (ATAI) | Germany | $0.265B | 0.00 |
| Daxor (DXR) | United States | $0.042B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.014B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.011B | 0.00 |
| Ontrak (OTRK) | United States | $0.008B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.001B | 0.00 |